EDGAR Filing Documents for 0001654954-21-005450

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-21-005450

Filing Date

2021-05-11

Accepted

2021-05-11 16:26:13

Documents

Period of Report

2021-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	sbfm_10q.htm	10-Q	539796
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	14181
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	13833
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32.1	6994
5	IMAGE	sbfm_fig1.jpg	GRAPHIC	11722
6	IMAGE	sbfm_fig2.jpg	GRAPHIC	18269
7	IMAGE	sbfm_fig3.jpg	GRAPHIC	13399
8	IMAGE	sbfm_fig4.jpg	GRAPHIC	9679
	Complete submission text file	0001654954-21-005450.txt		1535252

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	sbfm-20210331.xml	EX-101.INS	99305
10	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20210331.xsd	EX-101.SCH	13637
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20210331_cal.xml	EX-101.CAL	35351
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20210331_def.xml	EX-101.DEF	16320
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20210331_lab.xml	EX-101.LAB	104508
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20210331_pre.xml	EX-101.PRE	80926

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)